Pınar Senkalfa Burcu, Sismanlar Eyuboglu Tugba, Aslan Ayse T, Ramaslı Gursoy Tugba, Soysal Azime S, Yapar Dilek, İlhan Mustafa N
Department of Pediatrics, Gazi University Faculty of Medicine, Ankara, Turkey.
Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.
Pediatr Pulmonol. 2020 Aug;55(8):2128-2134. doi: 10.1002/ppul.24900. Epub 2020 Jun 26.
We aimed to evaluate anxiety among children with cystic fibrosis (CF) and their mothers related to the COVID-19 pandemic.
A total of 45 patients with CF and their mothers were enrolled in the study together with 90 age-matched healthy children and their mothers as a control group. The State and Trait Anxiety Inventory (STAI) was administered by teleconference with children aged 13 to 18 years old and their mothers. The STAI for children was administered with children aged 9 to 12 years. Results were compared with age-matched healthy children and their mothers. The relationship between anxiety scores of children with CF and their mothers was evaluated by comparing with clinical data of children with CF. At the conclusion of the teleconference, mothers were asked whether their anxiety had changed as a result of the interview.
It was found that healthy children aged 13 to 18 years had higher state anxiety scores than age-matched children with CF. Mothers of children with CF had higher trait anxiety scores, especially those of children aged 0 to 12 years, than mothers of healthy children (P < .05). For mothers of children with CF, state anxiety scores were higher among those whose children had chronic Pseudomonas infection (P < .05). Most mothers of children with CF stated that their anxiety decreased following the interview.
The COVID-19 pandemic may increase anxiety among mothers of children with CF as well those with healthy children. However, COVID-19 had no effect on the anxiety of children with CF. Informing parents of children with CF about COVID-19 by teleconference may decrease anxiety.
我们旨在评估囊性纤维化（CF）患儿及其母亲在新冠疫情期间的焦虑状况。
本研究共纳入45例CF患儿及其母亲，同时纳入90例年龄匹配的健康儿童及其母亲作为对照组。通过电话会议对13至18岁的患儿及其母亲进行状态-特质焦虑问卷（STAI）测评。对9至12岁的患儿采用儿童版STAI进行测评。将结果与年龄匹配的健康儿童及其母亲进行比较。通过与CF患儿的临床资料对比，评估CF患儿及其母亲焦虑评分之间的关系。在电话会议结束时，询问母亲们她们的焦虑是否因访谈而有所改变。
发现13至18岁的健康儿童的状态焦虑评分高于年龄匹配的CF患儿。CF患儿的母亲特质焦虑评分更高，尤其是0至12岁患儿的母亲，高于健康儿童的母亲（P < 0.05）。对于CF患儿的母亲，其孩子患有慢性铜绿假单胞菌感染的母亲状态焦虑评分更高（P < 0.05）。大多数CF患儿的母亲表示访谈后她们的焦虑有所减轻。
新冠疫情可能会增加CF患儿母亲以及健康儿童母亲的焦虑。然而，新冠疫情对CF患儿的焦虑没有影响。通过电话会议向CF患儿的家长通报新冠疫情相关信息可能会减轻焦虑。
